Adipose tissue, best known for its role in fat storage, can also suppress weight gain and metabolic disease through the action of specialized, heat-producing adipocytes. Brown adipocytes are located in dedicated depots and express constitutively high levels of thermogenic genes, whereas inducible 'brown-like' adipocytes, also known as beige cells, develop in white fat in response to various activators. The activities of brown and beige fat cells reduce metabolic disease, including obesity, in mice and correlate with leanness in humans. Many genes and pathways that regulate brown and beige adipocyte biology have now been identified, providing a variety of promising therapeutic targets for metabolic disease.
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Sedentary living and the consumption of calorie-dense food has precipitated a steep rise in obesity throughout the developed world. This is particularly alarming because of the vast array of obesity-associated diseases, including type 2 diabetes, heart disease, insulin resistance, hyperglycemia, dyslipidemia, hypertension and many types of cancer 1, 2 . The end results are an expanding population of chronically ill people, staggering health care expenses and a prediction that, for the first time, the current generation will have a shorter life span than previous generations [3] [4] [5] . There is thus an urgent need for new weight-loss treatments.
Brown adipose tissue (BAT) is a key site of heat production (thermogenesis) in mammals that has for many decades been considered an attractive target to promote weight loss. The heat produced by BAT is essential for the survival of small mammals in cold environments and for arousal in hibernators. Brown adipocytes in BAT are packed with mitochondria that contain uncoupling protein-1 (UCP1). UCP1, when activated, short circuits the electrochemical gradient that drives ATP synthesis and thereby stimulates respiratory chain activity. Heat is generated from the combustion of available substrates 6 and is distributed to the rest of the body through the circulation.
Clusters of UCP1-expressing adipocytes with thermogenic capacity also develop in white adipose tissue (WAT) in response to various stimuli 7 . These adipocytes have been named beige, 'brite' (brown in white), iBAT (induced BAT), recruitable BAT and wBAT (white adipose BAT). Similar to adipocytes in BAT, beige cells in mouse WAT are defined by their multilocular lipid droplet morphology, high mitochondrial content and the expression of a core set of brown fat-specific genes (for example, Ucp1, Cidea and Pgc1a (encoding peroxisome proliferator-activated receptor-γ coactivator 1-α)). Despite a common ability to undergo thermogenesis, brown and beige cells have many distinguishing characteristics and should be considered as distinct cell types (Fig. 1) . First, beige cells, at least those in the mouse subcutaneous depot, do not derive from the same embryonic (Myf5 (encoding myogenic factor 5)-expressing) precursors that give rise to brown adipocytes 8 . Second, a number of quantitative trait loci are associated with the induced development of beige but not brown adipocytes 9 , suggesting that these cell types are differentially regulated. Third, brown and beige adipocytes express distinct and distinguishing gene signatures 10, 11 . Fourth, a striking difference between the two cell types is that brown adipocytes express high levels of Ucp1 and other thermogenic genes under basal (unstimulated) conditions, whereas beige adipocytes express these genes only in response to activators such as agonists of the β-adrenergic receptor or peroxisome proliferator-activated receptor-γ (Ppar-γ) 12, 13 . Importantly, this trait is fat-cell autonomous, as brown fat cells increase their expression of thermogenic genes (for example, Ucp1) during adipogenesis in culture from preadipocytes without the addition of classical activators 14 .
A clear question is whether brown and beige fat cells have different functions. The answer to this question is still unknown and has not been well studied. However, a recent study has suggested that fully stimulated brown and beige adipocytes contain comparable amounts of Ucp1, suggesting that they have similar thermogenic capacities 10 . On the basis of these findings, the name beige for these cells might be misleading and is more applicable for describing the tissue that has undergone browning rather than the Ucp1 + adipocytes themselves. Aside from thermogenesis, it is highly probable that beige and brown adipocytes have other cell type-specific actions that have yet to be studied. For example, beige adipocytes may secrete certain factors that affect WAT function, systemic metabolism or both.
The biomedical interest in brown and beige adipocytes has centered on the capacity of these cell types to counteract metabolic disease, including obesity and type 2 diabetes. Indeed, increased activities of brown and beige adipocytes have been linked to obesity resistance in many mouse models [15] [16] [17] (Table 1 ). In humans, it was assumed for many years that there was too little brown fat present in adults to affect body weight. However, a few years ago, imaging studies revealed the presence of substantial deposits of UCP1-expressing adipocytes in adult humans, the mass, activity or both of which were lower in obese and older subjects [18] [19] [20] [21] [22] . The key question now is whether reduced thermogenic activity in fat cells is a cause or a consequence of weight gain in humans. Regardless of its natural role, increasing the activity of brown fat, beige fat or both through drugs or other methods holds tremendous promise for the treatment of metabolic disease.
Mitochondrial uncoupling has been tried as a weight-loss therapy. The chemical uncoupler 2,4-dinitrophenol (DNP) allows protons to leak across the mitochondrial membrane, mimicking the effect of activated UCP1 (ref. 23 ). In the 1930s, DNP was used widely as an effective diet pill to treat obesity, providing proof-of-concept support for mitochondrial uncoupling as an approach for weight loss. However, at high doses (which vary in different people), unregulated respiratory uncoupling in all cells causes dangerous side effects, including hyperthermia and death. Thus, the goal should be to develop strategies that enhance respiratory uncoupling selectively in adipose tissue by exploiting the mechanisms that naturally evolved to do this in brown and beige fat cells. 
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Oprd1
Not determined
Yes
Mice are resistant to weight gain and have enhanced thermogenesis in BAT. 178
Pctp
Not determined
Yes
BAT showed enlarged mitochondria and an increased expression of thermogenic genes. 179
Prkar2b
Not determined
Yes
Loss of Prkar2b causes a compensatory increase in the amount of RIα, which binds cAMP with higher affinity than Pkar2b, causing increased basal PKA activity and increased thermogenesis. 
184
Smad3
Yes No Smad3 represses Pgc-1α expression. Loss of Smad3 induces the expression of transcripts that correspond to increased thermogenesis.
185
Tnfrsf1a
Not determined
Yes
Increased expression of Ucp1 in BAT and of Ucp3 in muscle, resulting in increased oxygen consumption.
186
Trpv4
Yes Not determined KO mice are resistant to weight gain and have increased thermogenic gene expression in WAT mediated by a loss of ERK1-and ERK2-mediated effects on Pgc-1α.
187
Twist1
Not determined
Yes
Twist 1 binds to and inhibits Pgc-1α activity at target genes. Development of brown and beige adipocytes Brown adipocytes. BAT forms during embryonic development before other fat depots and is assumed to contain a uniform population of adipocytes. The major BAT depots in rodents are in the interscapular region (interscapular, axillary and cervical pads) embedded in and around deep back muscles. An interscapular BAT depot has also been noted in human infants, which regresses and is absent in adults 24, 25 .
Most brown fat cells originate from precursor cells in the embryonic mesoderm that also give rise to skeletal muscle cells and a subpopulation of white adipocytes 8, 26, 27 . These precursors transiently express Myf5 and Pax7, two genes that were previously thought to selectively mark skeletal myogenic cells in the mesoderm 8, 27 ( Fig. 2a) . Consistent with a developmental relationship between brown fat and muscle, brown fat precursor cells express a muscle-like gene signature 28 , and brown fat and muscle have related mitochondrial proteomes 29 . However, whether Myf5-expressing cells are multipotent or whether there are separate pools of Myf5-expressing precursors that contribute to muscle, brown fat and white fat remains to be tested.
Beige adipocytes. The embryonic origin and cell hierarchy of beige adipocytes is less clear. Beige and brown adipocytes probably come from distinct cell lineages, given that beige cells, at least in the subcutaneous depot, do not have a history of Myf5 expression 8, 26 . In formed WAT, an important question is whether beige adipocytes come from white adipocytes through transdifferentiation or arise through the de novo differentiation and maturation of precursors. Over a decade ago, Himms-Hagen et al. 30 found that most beige adipocytes arise from pre-existing (nondividing) cells that they presumed were mature adipocytes. Since then, Cinti and others have provided substantial evidence in support of the idea that large unilocular white adipocytes transform into beige adipocytes in response to cold or β3-adrenergic agonists 7 .
A new study from Wang et al. 31 used a pulse-chase fate-mapping technique in mice to revisit this issue. The authors pulse labeled mature adipocytes in WAT using LacZ . This labeling was indelible and heritable such that LacZ was constitutively expressed in the pulsed adipocytes and any of their descendents. After being pulsed, the mice were exposed to cold or treated with β3-adrenergic agonists to induce the formation of beige adipocytes. The results were clear-the majority of newly acquired Ucp1 + adipocytes in the subcutaneous inguinal depot were not marked by LacZ. This indicates that most, if not all, beige adipocytes (at least in this subcutaneous depot) arise from a precursor population rather than from pre-existing adipocytes (Fig. 2b) .
The thermogenic profile of beige adipocytes is reversible. Beige adipocytes acquired in WAT during cold exposure lose Ucp1 expression and are retained after mice are moved back to warmer conditions 32 (Fig. 2b) . When these mice are re-exposed to cold, the same cells again induce Ucp1 expression 32 . Interestingly, the cells marked by previous Ucp1 expression were not the only source of beige adipocytes during the second round of cold exposure. This suggests that beige adipocytes are retained and may function similarly to white fat cells for a certain period of time in animals that were previously cold. These beige adipocytes are presumably depleted through the normal mechanisms that control tissue turnover.
Another important question is whether beige and white adipocytes arise from different types of precursors. Petrovic et al. 12 found that a subset of adipocytes differentiated in vitro from the stromal vascular fraction (an enriched source of preadipocytes) of WAT induce Ucp1 expression in response to treatment with PPAR-γ activators; this suggests that some but not all preadipose cells are thermogenically competent. Recently, the Spiegelman laboratory used limited dilutions to clone preadipocyte cell lines from the stromal vascular fraction of subcutaneous (inguinal) WAT 10 . Through global gene profiling and differentiation analyses, the authors identified two types of preadipocytes-white and beige. Both types of committed precursors differentiated into lipid-laden adipocytes that lacked thermogenic characteristics under standard adipogenic conditions. However, only beige cells induced a thermogenic gene program when treated with β-adrenergic agonists. Notably, Cd137 and transmembrane We leave open the possibility that under some conditions, mature white fat cells can transdifferentiate into beige cells (small dashed arrow). In epididymal WAT, caloric excess causes bipotent progenitors to differentiate into white adipocytes, whereas β-adrenergic activators stimulate beige adipocyte development. TZD agonists of Ppar-γ promote beiging both by increasing the stability of Prdm16 and through the Sirt1-dependent deacetylation of Ppar-γ, which recruits Prdm16 to Ppar-γ target genes. β-adrenergic signaling drives the expression and activity of Pgc-1α in beige adipocytes. Pgc-1α is targeted by numerous repressors to block beige adipocyte development. Ac, acetylation. Debbie Maizels npg protein 26 (Tmem26) were identified as cell-surface markers for native beige precursors, thus enabling the direct purification of these cells from fat tissues. These data suggest that cold (through β-adrenergic agonists) triggers the differentiation of Cd137 + Tmem26 + precursor cells into Ucp1 + beige adipocytes and that beige cells require constant stimulation to maintain their thermogenic programming. In light of these recent studies, there does not seem to be much or any direct transformation of white into beige adipocytes, at least under physiological conditions. Beige adipocytes are most abundant in the inguinal WAT, which is a major subcutaneous depot in rodents 7 . However, Ucp1-expressing adipocytes are evident in most (if not all) WAT depots in response to cold exposure 7, 30, 33 . In perigonadal (visceral) fat of male mice, beige adipocytes develop from a population of precursors that also differentiates into white adipocytes 34 (Fig. 2b) . These bipotent precursors express platelet-derived growth factor receptor-α (Pdgfr-α) and are closely associated with blood vessels. After treatment of mice with β3-adrenergic agonists, these precursor cells proliferate, lose Pdgfr-α expression and differentiate into Ucp1 + adipocytes. Conversely, a high-fat diet stimulates the differentiation of Pdgfr-α + cells into white adipocytes 34 . This result is consistent with the finding that most or all white adipocytes descend from Pdgfra-expressing cells 35 . Importantly, cell-culture analyses have shown that single Pdgfr-α + cells can give rise to both Ucp1 -and Ucp1 + (beige) adipocytes 34 .
In the mature adipocyte tracing studies of Wang et al. 31 , very little beige fat recruitment, but a surprising amount of white adipogenesis, was detected in the perigonadal WAT of mice exposed to cold for 1-3 d or treated with a β3 agonist for 7 d. Why new white fat cells develop during cold exposure is unclear. It is also surprising that so few Ucp1 + cells were detected. Perhaps the exposure was too short to elicit a full beige recruitment in the newly developed adipocytes? It would be interesting to examine the effects of chronic cold in these mice, as this is known to lead to the extensive browning of WAT depots.
The prevalence of beige adipocytes within different human WAT depots has not been carefully evaluated. However, it is known that human WAT contains precursor cells that are capable of expressing UCP1 and other brown and/or beige characteristics, particularly in response to PPAR-γ activation 36 . Additionally, it was (and still is) unclear whether the deposits of UCP1-expressing adipocytes identified by fluorodeoxyglucose positron emission tomography (FDG-PET) in adult humans are analogous to beige or brown fat. Wu et al. 10 and Sharp et al. 11 reported that supraclavicular tissue, the largest FDG-PET-positive depot in humans, expresses selective markers of beige fat cells. By contrast, Jesperson et al. 37 found that tissue and in vitro-differentiated adipocytes from this depot express both brownand beige-specific markers. A different depot in the neck region was shown to have the molecular characteristics of mouse brown fat 38 . Typing these depots as brown or beige on the basis of their expression levels of a few mouse marker genes that have no known function(s) has not been conclusive thus far. Functional marker genes or assays are needed to better categorize the different human and mouse fat depots and cell types, and researchers should continue to study the biology and therapeutic potential of both classic BAT and inducible beige fat.
Regulation of brown and beige adipocytes by PRDM16
Prdm16 is a large zinc finger-containing transcriptional factor that is highly expressed in mouse BAT relative to visceral WAT 39 . PRDM16 expression is also substantially enriched in human BAT relative to adjacent subcutaneous WAT 22, 40 . Ectopic Prdm16 expression converts myoblasts and white fat precursors into thermogenic, Ucp1-containing adipocytes 8 . Mechanistic studies have suggested that Prdm16 acts primarily through binding to and modulating the activity of other transcriptional factors, including c/EBPβ, Ppar-γ, Ppar-α and Pgc-1α 8, 39, 41, 42 . Knockdown of Prdm16 ablates the thermogenic characteristics of brown fat cells while also causing an increase in the expression of white fat-specific and muscle-specific genes 8, 39 . Together these studies have strongly suggested that PRDM16 is a key driver of brown fat cell fate.
The importance of Prdm16 in brown fat cell differentiation prompted us to examine whether Prdm16 also has a role in the development of beige adipocytes. After analyzing various mouse WAT depots, we noted that Prdm16 is highly expressed in the depots that are most prone to beiging, especially the inguinal WAT 16 . Importantly, reduction of Prdm16 expression blocks the induction of a thermogenic program in cultured subcutaneous adipocytes and decreases the recruitment of beige adipocytes in WAT in response to β-adrenergic or Ppar-γ agonists 16, 43 . Conversely, transgenic expression of Prdm16 in adipose tissues of mice stimulates beige adipocyte development to counteract high fat diet-induced weight gain and improve glucose tolerance 16 .
Several factors have been shown to regulate brown and beige adipocyte differentiation by modulating Prdm16 expression or activity. Notable among these factors is bone morphogenetic protein 7 (Bmp7), a signal that is essential for brown fat development, which increases the amounts of Prdm16 mRNA in brown and white fat precursor cells [44] [45] [46] . Additionally, thiazolidinediones (TZDs), which agonize Ppar-γ, induce thermogenic gene expression in fat cells through effects on Prdm16 (refs. 43, 47) . Interestingly, the muscle-enriched microRNA miR-133 directly targets and reduces the amounts of Prdm16 to block both brown and beige adipose development [46] [47] [48] . Cold exposure suppresses miR-133 expression in fat cells, which leads to increased amounts of Prdm16 and increased expression of downstream thermogenic target genes 48 . Compared with wild-type mice, mice lacking miR-133 express higher levels of Prdm16 in WAT and develop more beige adipocytes 49 . Intriguingly, miR-133 is also highly expressed in mouse adult muscle stem cells, where it suppresses Prdm16 expression 50 . Reduction of miR-133 in regenerating muscle causes the ectopic development of brown adipocytes and an associated increase in energy expenditure.
Roles of brown and beige fat in regulating metabolism BAT has long been viewed as a tissue that is key for maintaining body temperature in response to cold. In 1979, Rothwell and Stock first reported that BAT was also activated in rodents when they overeat as a mechanism to preserve energy balance and limit weight gainso-called diet-induced thermogenesis 51 . Consistent with this mechanism, mice genetically engineered to have less BAT gain more weight than control mice 52 . However, for many years it was unclear why Ucp1-deficient mice, which are cold intolerant (and thus have defective BAT), resisted rather than developed obesity 53 .
An important study by the Cannon and Nedergaard group revealed that Ucp1-deficient mice gain more weight than wild-type controls but only when they are housed under thermoneutral (28-30 °C) conditions 54 . At room temperature (20-22 °C), mice are cold and must therefore expend extra energy to defend their body temperature. Ucp1-deficient mice, which cannot use BAT, activate alternative thermogenic mechanisms 55, 56 . This is thought to conceal the effect of brown fat and Ucp1 on energy balance. Consistent with this idea, old Ucp1-deficient mice, which are larger and less cold sensitive than npg younger mice, become obese even at ambient temperature 57 . The marked impact of temperature on physiology has been overlooked by much of the rodent research community. In the area of metabolism, cold stress and its effects have undoubtedly confounded many studies. Because people tend to live at thermoneutrality with the aid of clothing and heating, a compelling argument could be made that most or even all metabolic studies in mice should be conducted under thermoneutral conditions.
The obesogenic effect of Ucp1 deficiency in warm mice indicates that the activity of brown fat, beige fat or both can affect energy balance, but the magnitude (and importance) of this effect in freeliving mice or humans is uncertain. Notably, previous studies in rats housed at thermoneutrality failed to find any substantial contribution of BAT activity to diet-induced thermogenesis 58 . Moreover, Anunciado-Koza et al. 55 did not observe changes in adiposity in their studies of Ucp1 knockout mice when the mice were housed under varying temperature conditions. In addition, increases in BAT or Ucp1 activity in response to high-fat feeding are not consistently observed 59 . These divergent findings may provide an opportunity to identify modifying factors that affect BAT or Ucp1 activity and energy balance. Are there specific dietary components that are needed to recruit BAT efficiently? What are the genetic or strainspecific effects? Do the microbiome or other environmental factors in different vivariums play a part?
Regardless of whether BAT has a major physiological role in body weight regulation in mice and humans, there is no question that expanding the activity of brown fat, beige fat or both in mice through genetic manipulation, drugs or transplantation suppresses metabolic disease [15] [16] [17] 47, [60] [61] [62] [63] (Table 1) . These results imply that counterregulatory mechanisms (for example, increased food intake), which might have been predicted to offset the effects of expanded BAT activity to preserve energy balance, are not fully effective in mice. Notably, in some cases, the beiging of WAT and a highly correlated antiobesity effect happen without evidence of increased BAT function. For example, the hormone irisin raises energy expenditure through selective actions in beige adipocytes 60 . Similarly, transgenic expression of Prdm16 in all fat tissues promotes the beiging of WAT and resistance to obesity without increasing BAT mass or the amounts of Ucp1 mRNA 16, 17 . In addition, transgenic expression of Ucp1 in adipocytes suppresses obesity despite leading to a reduction in BAT mass 17 . These results raise an obvious question-do beige adipocytes have a more important physiological role than BAT in fighting obesity? This seems unlikely, given that a high-fat diet generally decreases the expression of thermogenic genes in WAT coincident with increases in WAT mass in mice 59 .
Mice with increased activity of brown fat, beige fat or both resist weight gain but also display improvements in systemic metabolism, including improved glucose tolerance and increased insulin sensitivity 15, 16, 60, 64 . Along these lines, activated brown fat takes up and metabolizes large quantities of lipid from the bloodstream 65 , which has beneficial effects on metabolism. In models in which the activity of beige fat seems to be selectively increased, such as mice with transgenic expression of Prdm16 in their fat tissue 16 and irisin-treated mice 60 , the improvement in glucose tolerance seems disproportional to the modest effects on body weight. We speculate that the increased proportion of beige to white adipocytes in WAT modulates systemic insulin action through nonthermogenic mechanisms, perhaps by altering the secretome of adipose tissue. Additionally, thermogenic fat cells, not yet classified as brown or beige, that surround blood vessels (perivascular adipose) have been suggested to protect against the development of atherosclerosis 66 . Thus, the potential therapeutic uses of brown and beige fat go beyond obesity and should be considered for various metabolic disturbances, including type 2 diabetes, insulin resistance, atherosclerosis and lipid disorders.
Sympathetic nerve control of brown and beige fat
Cold is a dominant regulator of many aspects of BAT biology. Mice lacking BAT activity are cold intolerant because of defective nonshivering thermogenesis 53 . Cold, sensed by various mechanisms, including thermoreceptors in the skin, elicits sympathetic outflow to BAT through an intricate neural circuitry (reviewed in ref. 67 ). In addition to nerve terminals, alternatively activated macrophages in BAT produce catecholamines in response to cold 68 . Norepinephrine agonizes adrenergic receptors on adipocytes, which triggers a signal transduction cascade that leads to adaptive increases in the expression of thermogenic genes 69 (Fig. 3) . Prolonged cold exposure also stimulates the proliferation and differentiation of brown precursor cells to expand BAT mass and increase thermogenic capacity 70 . Conversely, at warmer housing temperatures or in surgically denervated BAT, the expression of Ucp1 and other thermogenic factors are substantially reduced in mice 71, 72 .
Sympathetic nerve activity also acutely stimulates heat production by activating Ucp1 function. Classic studies have shown that fatty acids, rapidly released from lipid droplets in response to nerve activity, increase proton leak through UCP1 (reviewed in ref. 73) . Recently, Fedorenko et al. 74 discovered that long-chain fatty acids generated in the inner mitochondrial membrane by phospholipase A2 (Pla2) bind Ucp1 directly and are required for proton transport (Fig. 3) . An important but often overlooked tenet is that UCP1 does not increase the respiratory activity of cells under basal conditions 75, 76 . Therefore, therapeutic approaches that expand brown adipocytes, beige adipocytes or both without also promoting activation could be unproductive. However, in many people, an expanded brown fat compartment, beige fat compartment or both may be sufficiently activated by daily tonic stimuli (for example, food, cold and exercise) to achieve therapeutic effects.
Cold is also a classic activator of beige adipocyte development and function. Mice housed in the cold undergo a marked remodeling of their WAT that is characterized by an accumulation of beige adipocytes 7 . This effect can be mimicked by treating mice with β3-adrenergic activators such as CL 316,243 (refs. 7,30,61,62,77-80) . Interestingly, the propensity of WAT depots to undergo beiging is highly correlated with their density of sympathetic nerve fibers 81 . However, other adipose cell-and/or tissue-autonomous factors must be involved, as systemic β3-agonist administration (thereby bypassing the central nervous system) causes certain depots to beige more than others 33 . Many of the effects of chronic cold on adipose tissues are recapitulated in mice that have elevated expression of forkhead box protein C2 (Foxc2) in adipocytes 15 . Specifically, Foxc2 increases BAT mass, induces beige fat cell development, drives mitochondrial biogenesis and promotes angiogenesis in fat tissue [82] [83] [84] . Foxc2 functions in fat cells to a large extent by driving the expression of the R1α regulatory subunit of protein kinase A (PKA, encoded by Prkar1a) 15, 85 , thus sensitizing adipocytes to the effects of catecholamines. These results suggest that the adipocytes instigate most of the tissue remodeling that occurs in response to norepinephrine.
The discovery of the mouse β3-adrenergic receptor (β3-AR), which is expressed mainly in fat and whose agonism activates thermogenesis (reviewed in ref. 72) , generated tremendous excitement for therapeutic possibilities in humans. However, treatment of humans with β3-AR agonists never lived up to the forecasted predictions 86 . The observed difficulties seemed to be due to receptor differences between mice and humans, leading to off-target effects in humans, as well as poor pharmacokinetic properties and oral bioavailability 87 . These problems, compounded with the previously held tenet that adults have very little BAT, caused many companies to abandon their development of β3-AR agonists for the treatment of obesity. Future studies should consider whether β3-AR agonists could be used in combination with recruiters of brown fat, beige fat or both. Alternatively, it would be worth considering whether prescribed cold exposure could be used to activate brown fat, beige fat or both after augmentation by other pathways.
Cold exposure, which induces thermogenic features in adipose cells, also affects the developmental programs of other cell types in adipose tissue to coordinate and optimize heat production. For example, and as noted above, cold activates alternatively activated macrophages in BAT to produce catecholamines 68 . Cold also stimulates sympathetic nerve branching and recruitment during the browning response of WAT 81 . In addition, cold exposure induces the sprouting and growth of blood vessels in adipose to facilitate oxygen delivery and heat exchange 70, 72, 88 . This angiogenic effect is regulated through increased production of vascular endothelial growth factor (Vegf) by a mechanism that does not involve hypoxia [89] [90] [91] . Interestingly, Vegf secreted by adipose tissue also enhances the recruitment of brown and beige adipocytes through an unknown mechanism (Fig. 4) . In cultured brown adipocytes, Vegf enhanced cell survival and proliferation, whereas VEGF-neutralizing antibodies caused apoptosis 92 . Notably, overexpression of Vegf in adipose tissues of mice increases BAT mass, stimulates beiging and promotes a healthy metabolic profile 93, 94 . Vegf inhibition has also been shown to reduce metabolic disease in mice, although this effect was in the context of obese WAT that was already dysfunctional 94, 95 . Further studies will be needed to elucidate the mechanism(s) by which VEGF manipulates the fate of adipose tissue under different metabolic states.
PGC-1a controls the thermogenic activation of adipocytes Pgc-1α was discovered as a cold-induced interacting partner of Ppar-γ in brown fat 96 . On the basis of hundreds of studies, PGC-1α is now recognized as a master regulator of mitochondrial biogenesis and oxidative metabolism in many cell types. In adipocytes, Pgc-1α also induces the expression of Ucp1 and other thermogenic components 96, 97 . Surprisingly, however, BAT develops normally without Pgc-1α 98 , probably because of compensation by the related family member Debbie Maizels Figure 3 Catecholamine and natriuretic induction of thermogenesis. Sympathetic neurons exocytose catecholamines (dark green circles), which bind to β-adrenoreceptors, leading to activation of adenylyl cyclase (AC), increased cyclic AMP (cAMP; light green circles) concentrations and enhanced PKA activity. Natriuretic peptides (NP; red circles) bind natriuretic peptide receptor A (Npra), which activates guanylyl cyclase (GC) to increase the concentrations of cyclic GMP (cGMP; pink circles), leading to activation of PKG. Activated PKA and PKG use similar mechanisms to drive transcriptional responses in brown adipocytes through the activity of phosphorylated Creb and p38 Mapk. Specifically, p38 Mapk phosphorylates and activates Atf2 and Pgc-1α, which induce the transcription of downstream thermogenic genes, including Ucp1. Pgc-1α binds DNA through interactions with Ppar-γ, Ppar-α, retinoid X receptors (Rxrs) and thyroid receptor (TFx). Additionally, catecholamines increase the amounts of miR-196a, resulting in increased C/ebpβ expression, which helps drive the thermogenic gene program. Importantly, activation of PKA and PKG also acutely induces lipolysis. The free fatty acids (FFA; blue circles) released from lipid droplets are oxidized by mitochondria to produce heat. Proton leak through Ucp1 is activated by long-chain fatty acids (LCFA; green circles) released from the mitochondrial membrane by Pla2. AR, adrenergic receptor; P, phosphate; Gs, a G protein subunit. Debbie Maizels Figure 4 Secreted factors that recruit brown adipocytes, beige adipocytes or both. In rodents, a number of tissues and cell types have been found to secrete factors that regulate brown and beige adipose activity through systemic, autocrine and paracrine mechanisms. Neurons and alternatively activated macrophages secrete norepinephrine; cardiac tissue secretes natriuretic peptides; liver and BAT secrete Fgf21; muscle secretes irisin; and thyroid secretes the hormone T 4 (which is then converted to T 3 ). BAT also produces Bmp8b and Vegf, which increase thermogenic function in an autocrine manner. Additionally, orexin and Bmp7 promote brown fat development, but their cellular source is unknown. Oxr1, oxidation resistance 1; Alk7 (also called Acvr1c), activin A receptor type 1C.
npg Pgc-1β. Although it is not required for tissue development, Pgc-1α is essential for cold-induced or β-agonist-induced thermogenic activation of brown adipocytes 99,100 and the expression of thermogenic genes in WAT 101 (Fig. 2) . Thus, Pgc-1α is a central transcriptional effector of adrenergic activation in thermogenic adipocytes.
Pgc-1α expression and activity are regulated directly by the β-adrenergic signaling pathway 102 , providing a link between the physiological activator of brown fat thermogenesis and the transcriptional machinery in brown adipocytes (Fig. 3) . Specifically, Pgc-1α is phosphorylated and thereby activated by p38 mitogenactivated protein kinase (MAPK) in response to sympathetic stimulation 102, 103 . Activated Pgc-1α regulates the expression of thermogenic genes through its interactions with Ppar-γ, Ppar-α, thyroid receptor and other factors 96, 104, 105 , although a detailed mechanism to account for its selective effects at brown fat-specific genes is lacking. Pgc1a transcription also increases in response to β-adrenergic agonists through increases in the function of activating transcription factor-2 (Atf2) 102 .
Several transcription factors suppress thermogenesis by interfering with Pgc-1α activity (Fig. 2) . For example, the retinoblastoma family members pRb (also called Rb1) and p107 (also called Rbl1) repress Pgc-1α transcription to block the expression of brown genes in white adipose 106, 107 . Notably, pRb activity declines during the β-adrenergicinduced beige conversion of WAT 107 . The nuclear co-repressor Rip140 (also called Nrip1) binds Pgc-1α and blocks its transcriptional activity at certain target genes 108 . The nuclear receptor Lxr-α (also called Nr1h3) also blocks Ucp1 expression by recruiting Rip140 and displacing Pgc-1α at an Lxr-binding site 109 .
Specific functions for the general adipogenic machinery PPAR-γ and members of the c/EBP protein family orchestrate the general differentiation program in all adipose lineages 110 but are also deployed to activate specific thermogenic genes in brown and beige adipocytes. For example, C/ebpβ is present at higher amounts in BAT relative to WAT, and its amounts increase further in response to cold 42 . In WAT, β-adrenergic agonists increase the amounts of C/ebpβ through miRNA-mediated degradation of Hoxc8, a repressor of C/ebpβ transcription 111 (Fig. 3) . Loss of C/ebpβ is associated with defective thermogenesis, whereas increasing the amounts of C/ebpβ in white fat cells triggers a brown fat transcriptional profile 42, [112] [113] [114] .
The master adipogenic factor Ppar-γ also controls the expression of brown fat-specific genes, including Ucp1, particularly in response to β-adrenergic activators 102, 103, 115 . Genome-wide analyses have demonstrated that Ppar-γ binds and regulates distinct target genes in brown and white fat cells 116, 117 . We recently discovered that Ebf2, a helix-loop-helix transcription factor, regulates Ppar-γ activity to drive the expression of Prdm16 and a brown fat fate 116 (Fig. 2) . Ebf2 seems to function, at least in part, by facilitating the recruitment of Ppar-γ (and probably other factors) to brown fat-specific genes. Ebf2-deficient mice develop fatty tissue with the molecular and morphological characteristics of white fat in the areas where brown fat normally forms.
Activation of Ppar-γ by synthetic TZD agonists enhances thermogenic gene expression in both white and brown adipocytes 12, [118] [119] [120] [121] [122] . TZDs induce UCP1 expression and increase mitochondrial biogenesis in adipocytes from mice and humans 12, 36, 123 . This enables TZDtreated adipocytes to undergo UCP1-mediated increases in respiration in response to β-adrenergic activators 12, 36, 43 . Mechanistically, TZDs seem to act in large part through Prdm16 to activate a thermogenic program. In particular, TZD treatment stabilizes Prdm16 protein to increase its amounts in fat cells 43 and also enhances the interaction of Prdm16 with Ppar-γ (Fig. 2) . Sirtuin 1 (Sirt1) has a role in this TZD-driven process by deacetylating Ppar-γ to facilitate the docking of Prdm16. In vivo, activation of Sirt1 promotes the browning of WAT and resistance to obesity 47 , suggesting that Sirt1 activators might have a use as weight-loss agents.
In the clinic, TZDs, although associated with unwanted side effects, are highly effective in the treatment of type 2 diabetes by enhancing insulin action. Given that beige adipocytes improve insulin sensitivity, it is reasonable to speculate that TZDs may act, at least in part, by inducing beige fat development. However, non-TZD PPAR-γ modulators such as MRL24 promote insulin sensitivity but have little effect on Ucp1 expression 43, 124 . Moreover, TZDs are associated with weight gain and increased adipocyte development in rodents and humans rather than weight loss. This effect may be due to a blunting effect that TZDs have on the sympathetic activation of adipocytes 125, 126 , which would block UCP1 function. As mentioned earlier, it would be worth exploring treatments that combine TZDs with UCP1 activators, such as β3-selective adrenergic agonists.
New brown-and beige-fat recruiters and activators Sympathetic nerve activity was previously widely believed to be the primary or only physiological signal that activates BAT thermogenesis and induces beige adipocyte development. Although β-AR signaling is undoubtedly a central regulator of these processes, several other hormones and factors have now been shown to regulate energy expenditure in adipose tissue (Fig. 3) and have been discussed comprehensively in recent reviews 13, 127, 128 . Here we describe secreted and systemic factors that affect brown and beige fat and seem to be particularly promising for therapeutic development.
Irisin. In skeletal muscle, Pgc-1α orchestrates the adaptive response to exercise, including increased mitochondrial biogenesis, switching from fast to slow muscle fibers and angiogenesis 129 . Unexpectedly however, increasing the amounts of Pgc-1α in muscle protects sedentary mice from obesity 130 . In a search for effectors of the enhanced energy expenditure in these animals, Spiegelman and his colleagues discovered that the WAT of Pgc-1α transgenic mice contained more beige adipocytes than that of wild-type mice 60 . They identified Fndc5 (encoding fibronectin type III domain containing 5) as a Pgc-1α target gene and showed that its product was secreted from myocytes in the form of a previously undiscovered hormone, which they called irisin. Irisin stimulates the browning of WAT through specific actions on the beige preadipocyte population 10 (Fig. 4) .
Circulating concentrations of irisin increase in mice and humans by exercise training. Remarkably, a modest increase in the serum concentrations of irisin in mice stimulates beige fat development, leading to enhanced glucose tolerance and suppressed weight gain 60 . Irisin is thus a compelling hormone for clinical development, as it has marked beneficial effects when used at near-physiological concentrations in mice.
Of course, as with any new hormone, there are many outstanding questions. What is the irisin receptor (or receptors) in beige fat precursors, and how does it signal to the transcriptional machinery? Is the cleavage of Fndc5 into irisin a regulated process? And what effects does irisin have on other tissues?
Fibroblast growth factor 21. Fibroblast growth factor 21 (FGF21) is a circulating hormone that regulates systemic energy levels and has npg become a focus of clinical trials for obesity, diabetes and cardiovascular disease. In BAT, Fgf21 expression is increased by cold exposure and has an important role in thermogenesis 131, 132 . Interestingly, there is a marked burst of Fgf21 production from the neonate liver in response to suckling-this effect is probably crucial for activating BAT thermogenesis at a time when animals are especially vulnerable to hypothermia 133 . Consistent with this hypothesis, administration of Fgf21 to fasted neonates augments the thermogenic gene program in BAT. In WAT, Fgf21 increases the amounts of Pgc-1α to drive beige adipocyte recruitment in response to cold 134, 135 .
Fgf21 has many desirable effects on metabolism in fed animals, including increased glucose uptake into peripheral tissues, improved insulin sensitivity and weight reduction 134, 136, 137 . Some of these actions may be mediated, at least in part, by stimulating fatty acid oxidation and energy dissipation pathways in adipocytes. Unfortunately, however, Fgf21 has also been shown to cause bone loss, which will need to be overcome if this hormone is to be used for clinical applications in obesity 138 .
Natriuretic peptides. Atrial natriuretic peptide and brain-type natriuretic peptide are released by the heart in response to heart failure or pressure overload. These factors reduce blood volume, blood pressure and cardiac output by dilating blood vessels and promoting salt and fluid excretion from the kidneys. Atrial natriuretic peptide is also known to promote lipolysis in adipocytes. Notably, high circulating concentrations of natriuretic peptides have also been associated with weight loss in humans 139, 140 .
Bordicchia et al. 64 recently discovered that increased concentrations of natriuretic peptides in mice promote beige adipocyte development in WAT and increase thermogenic gene expression in BAT. These changes are due to a direct effect of natriuretic peptides on adipose cells. Mechanistically, natriuretic peptides trigger lipolysis and browning through activation of cyclic GMP-dependent protein kinase (PKG). PKG works in parallel with the more familiar β-adrenergic-PKA pathway to trigger lipolysis and stimulate thermogenesis (Fig. 3) .
The effects of natriuretic peptides on brown and beige adipogenesis suggest that the control of adaptive thermogenesis is more complex than is currently appreciated. Cardiomyocytes, a cell type that is thought to have little crosstalk with adipocytes, can markedly alter the gene expression and function of adipose through the secretion of potent cardiometabolic hormones 64 . Importantly, cold increases the concentrations of natriuretic peptides, suggesting that this browning system may have evolved, perhaps in epicardial fat, to safeguard cardiac function in animals during cold exposure. Systemic elevation of the concentrations of natriuretic peptides would probably have many undesirable off-target effects, but pharmacological targeting of this pathway in adipocytes could be considered.
BAT activators with central and peripheral actions. Bmp8b is produced by mature brown fat cells and functions to amplify the thermogenic response of brown adipocytes to adrenergic activators 141 (Fig. 4) . Interestingly, Bmp8b is also expressed in certain hypothalamic nuclei. Injection into the brain with Bmp8b increases the sympathetic outflow to BAT but not other tissues and leads to weight loss in mice 141 . Although more studies are needed to assess the effect of Bmp8b on other tissues, Bmp8b is a promising target for therapeutics at this stage.
Other factors have been shown to augment BAT activity through both central and peripheral actions. For example, thyroid hormone directly induces the expression of thermogenic genes in brown adipocytes through the actions of thyroid receptors and also functions centrally to activate BAT [142] [143] [144] . Along similar lines, the neurotransmitter orexin augments BAT function by regulating sympathetic outflow and through directly promoting brown fat precursor differentiation 145, 146 (Fig. 4) . Targeting molecules, such as BMP8B, orexin and thyroid hormone, that both recruit and activate brown fat may be particularly effective in promoting energy expenditure and weight loss in humans.
Outlook and challenges
There is persuasive evidence from animal models that enhancement of the function of brown adipocytes, beige adipocytes or both in humans could be very effective for treating type 2 diabetes and obesity. Moreover, there are now an extensive variety of factors and pathways that could potentially be targeted for therapeutic effects. In particular, the discoveries of circulating factors, such as irisin, Fgf21 and natriuretic peptides, that enhance brown and beige fat function in mice have garnered tremendous interest. However, there are several issues to consider with regard to therapies targeted at brown fat, beige fat or both.
First, many of the thermogenic inducers, such as irisin, Bmp8b, orexin, natriuretic peptides and Sirt1, were only identified recently as having effects on the biology of brown and beige fat. Although the early findings are very promising, many more studies will be needed to assess the potency of these factors on brown and beige fat under a variety of experimental conditions. As a related point, very few studies have explored the mechanisms of brown and beige adipocyte recruitment in human cells and tissues. Given the depot-specific mechanisms of beige fat recruitment in mice, this trait is probably highly variable among human fat depots. Defining the cell type(s) within human fat depots that can undergo efficient thermogenic activation and examining which pathways promote this process will be an important avenue of future research.
Second, even if thermogenic tissue can be pharmacologically expanded in humans, it must still be efficiently activated. Most available studies have used mice housed below their thermoneutrality, which consequently increased the sympathetic outflow to fat. Thus, brown fat-and beige fat-based therapies will probably need to expand the number of thermogenic fat cells(s), activate them or both. Molecules, such as Bmp8b, that increase the sensitivity of brown fat cells to adrenergic stimuli could be particularly valuable. Third, energy balance is tightly controlled by homeostatic mechanisms. Despite enormous fluctuations in food intake and physical activity, the average person shows relative stability in their weight over long periods of time. By virtue of this fact, most individuals that lose weight tend to gain it back. Even if brown fat thermogenesis can be ramped up to increase calorie consumption, the body may compensate for the calorie deficit by increasing hunger or increasing the metabolic efficiency of other tissues such as muscle.
